- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04247529
Effects of Prior Exposure to Conflicting Health Information on Responses to Subsequent Unrelated Health Messages
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60603
- NORC at the University of Chicago (online only)
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- 18+ U.S. adults
- Members of NORC's AmeriSpeak Panel (https://amerispeak.norc.org/Pages/default.aspx)
- Able to complete web-based survey
- Able to read in English
Exclusion Criteria:
- None
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Placebo komparator: No exposure to conflict
|
At 2 time points across a ~28-day period, participants will be exposed to news stories and social media posts about 6 health topics: mammography screening, prostate-specific antigen (PSA) testing, Vitamin D supplementation, carbohydrate consumption, alcohol consumption, and breastfeeding.
Participants in the no conflict (comparator) group will have no conflicting information included in these news and social media posts.
|
Eksperimentel: Exposure to conflict
|
At 2 time points across a ~28-day period, participants will be exposed to news stories and social media posts about 6 health topics: mammography screening, prostate-specific antigen (PSA) testing, Vitamin D supplementation, carbohydrate consumption, alcohol consumption, and breastfeeding.
Participants in the conflict (experimental) group will have conflicting information added to these news and social media posts.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Negative affective responses
Tidsramme: Up to 42 days
|
|
Up to 42 days
|
Counterarguing
Tidsramme: Up to 42 days
|
• Participants are asked to indicate the extent to which they agree or disagree with 4 statements (randomly ordered; response options: 1 "strongly disagree" to 5 "strongly agree"):
|
Up to 42 days
|
Reactance/threat to freedom
Tidsramme: Up to 42 days
|
• Participants are asked to indicate the extent to which they agree or disagree with the following statement (response options: 1 "strongly disagree" to 5 "strongly agree"): "I felt like the ad was trying to manipulate me"
|
Up to 42 days
|
Other negative cognitive responses to ad claims
Tidsramme: Up to 42 days
|
• Participants are asked to indicate whether "the claims in the ad I just saw are" (randomly ordered; response options: 1 "strongly disagree" to 5 "strongly agree"): exaggerated, flawed, believable (reverse coded), reasonable (reverse coded)
|
Up to 42 days
|
Perceived argument strength
Tidsramme: Up to 42 days
|
• Participants are asked to indicate the extent to which they agree or disagree with 2 statements (randomly ordered; response options: 1 "strongly disagree" to 5 "strongly agree"):
|
Up to 42 days
|
Response efficacy
Tidsramme: Up to 42 days
|
• Participants are asked to respond to two items, presented in random order:
|
Up to 42 days
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 2019NTLS140
- R21CA218054 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kommunikationsforskning
-
Misr International UniversityAfsluttetAnmeldelse, Research PeerEgypten
-
University of MinnesotaNational Institute on Minority Health and Health Disparities (NIMHD); S...AfsluttetTeenagers sundhed | Ungdomsskoleforbundethed | Community Based Participatory Research MethodsForenede Stater
-
Nantes University HospitalIMT Mines Albi - France (https://www.imt-mines-albi.fr/)UkendtEmergency Medical Service Communication Systems, Health Care
-
Autism SpeaksUniversity of California, Los Angeles; Vanderbilt University; Hugo W. Moser...AfsluttetJoint Engagement + Enhanced Milieu Training | Joint Engagement + Enhanced Milieu Training + Augmentative Communication (AAC)Forenede Stater
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Washington...Aktiv, ikke rekrutterendeSkadereduktion | Alkoholbrug, uspecificeret | Hjemløshed | Community Based Participatory ResearchForenede Stater
-
Imperial College LondonImperial College Healthcare NHS TrustAfsluttetResearch With Clinical Staff in Stroke RehabilitationDet Forenede Kongerige
-
University of Wisconsin, MadisonNational Institute on Aging (NIA); Arizona State UniversityIkke rekrutterer endnuWisconsin Alzheimers Disease Research Center | Wisconsin Registry for Alzheimers ForebyggelseForenede Stater